SCHEMBL20042816

SCHEMBL20042816

Cc1nc2c(c(N3CCC3)n1)CN(C(=O)C1CCC(C)CC1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.45
GPR55 Q9Y2T6 3/20 0.45
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.37
NR4A1 P22736 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 2/20 0.37
HTT P42858 2/20 0.37
HPGD P15428 2/20 0.37
USP2 O75604 1/20 0.37
GRM5 P41594 2/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 1/20 0.34
GBA1 P04062 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042806 0.91 CNR1 (0.47) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042800 0.91 CNR1 (0.45) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042764 0.90 CNR1 (0.49) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042660 0.89 CNR1 (0.39) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042706 0.87 ALDH1A1 (0.43) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042762 0.86 CNR1 (0.40) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042779 0.86 GPR55 (0.39) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042735 0.85 CNR2 (0.41) CNR1GPR55TSHRLMNANR4A1
SCHEMBL20042793 0.83 SMN1; SMN2 (0.37) CNR1GPR55TSHRLMNANR4A1
Hydrochloric Acid SCHEMBL31615057 0.82 CNR1 (0.36) CNR1GPR55TSHRLMNANR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed